General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
2025 · 2nd Quarter (Apr 1 - June 30)
GLAXOSMITHKLINE
Filed by EAST END GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Termination
- Posted
- Jul 17, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- EAST END GROUP, LLC
- Client
- GLAXOSMITHKLINE
- Filing UUID
- d1d49c92-4443-40fd-b1c1-ee874a5e2d73
- Termination date
- Jun 30, 2025
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.